PLK4: a promising target for cancer therapy
Authors:
- 6 September 2019
- journal article
- review article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 145 (10) , 2413-2422
Abstract
Polo-like kinase 4 (PLK4) is a serine/threonine protein kinase that regulates centriole duplication. PLK4 deregulation causes centrosome number abnormalities, mitotic defects, chromosomal instability and, consequently, tumorigenesis. Therefore, PLK4 has emerged as a therapeutic target for the treatment of multiple cancers. In this review, we summarize the critical role of centrosome amplification and PLK4 in cancer. We also highlight recent advances in the development of PLK4 inhibitors and discuss potential combination therapies for cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81270598, 81473486, 81770210)
- Key Research and Development Program of Shandong Province (2018CXGC1213)
- Doctoral Foundation of Shandong Province (2017GSF18189)
This publication has 72 references indexed in Scilit:
- p53 can repress transcription of cell cycle genes through a p21WAF1/CIP1-dependent switch from MMB to DREAM protein complex binding at CHR promoter elementsCell Cycle, 2012
- The Structure of the Plk4 Cryptic Polo Box Reveals Two Tandem Polo Boxes Required for Centriole DuplicationStructure, 2012
- Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor PrognosisPLOS ONE, 2012
- Polo-like kinase 4 controls centriole duplication but does not directly regulate cytokinesisMolecular Biology of the Cell, 2012
- NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic MalignanciesMolecular Cancer Therapeutics, 2012
- Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous miceBMC Cancer, 2011
- Plk4 is required for cytokinesis and maintenance of chromosomal stabilityProceedings of the National Academy of Sciences, 2010
- Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stabilityJournal of Cell Biology, 2010
- Plk4-Induced Centriole Biogenesis in Human CellsDevelopmental Cell, 2007
- BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In VivoCurrent Biology, 2007